YTHDF2 negatively correlates with tumor immune infiltration in small cell lung cancer
Journal of Molecular Histology · 2023
DOI: 10.1007/s10735-023-10129-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Histology, 2023. Verfasst von Gang Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Esophageal Mediastinal and Lymphatic Oncology (Chemoradiotherapy), Zhongnan Hospital of Wuhan University, Wuhan, Hubei, P.R. China. Hauptthemen laut MEDLINE: Small Cell Lung Carcinoma, Lung Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
In recent times, RNA modifications have garnered increased attention due to their involvement in the onset and progression of tumors, with N6-methyladenosine (m6A) modification being the most prevalent form. YTHDF2 is an m6A reading protein that can modulate RNA stability, transcription, and translation. This study aimed to explore the role of YTHDF2 in small cell lung cancer (SCLC) by collecting 20 SCLC patients from our hospital (cohort 1) and 48 Chinese SCLC patients from the GEO database (cohort 2). We evaluated the prognostic value of YTHDF2 using Kaplan-Meier survival analysis, Log-rank test, and Cox regression analysis. Additionally, we employed Gene Set Enrichment Analysis (GSEA) to screen different signaling pathways. We also investigated the correlation between the expression of m6A-related genes and SCLC molecular subtype and tumor immune microenvironment (TIME). Furthermore, we utilized multiplex immunofluorescence (mIF) staining to validate the immune infiltration of SCLC patient tissue sections. Our study revealed that YTHDF2 is an independent prognostic factor, which high expression is associated with low overall survival rate in SCLC. Low expression of YTHDF2 in SCLC tumors may enhance the molecular subtype transition from neuroendocrine (NE) to non-neuroendocrine (non-NE) subtype. Low YTHDF2 expression was closely associated with high immune infiltration, immune checkpoints, and other immune-related molecular features. Additionally, mIF detection showed a correlation between the low expression of YTHDF2 and CD4 + T cells and CD8 + T cells. Taken together, YTHDF2 could serve as a potential prognostic biomarker negatively correlated with tumor immune infiltration in SCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Esophageal Mediastinal and Lymphatic Oncology (Chemoradiotherapy), Zhongnan Hospital of Wuhan University, Wuhan, Hubei, P.R. China.
- Genecast Biotechnology Co., Ltd, Wuxi, Jiangsu, P.R. China.
- Department of Thoracic Surgery, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, Guizhou, P.R. China.
- Department of Thoracic and Cardiovascular Surgery, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, P.R. China.
- Department of Pulmonary Oncology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, P.R. China. zjhzhongnan@163.com.
- Department of Thoracic Surgery, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, Guizhou, P.R. China. yangsongyisheng@163.com.
Zitieren
APA
Chen, G., Ren, D., Wang, Y., Wang, H., Zhang, J., & Yang, S. (2023). YTHDF2 negatively correlates with tumor immune infiltration in small cell lung cancer. Journal of Molecular Histology. https://doi.org/10.1007/s10735-023-10129-6
Vancouver
Chen G, Ren D, Wang Y, Wang H, Zhang J, Yang S. YTHDF2 negatively correlates with tumor immune infiltration in small cell lung cancer. Journal of Molecular Histology. 2023. doi:10.1007/s10735-023-10129-6
BibTeX
@article{Chen2023,
author = {Chen, Gang and Ren, Dandan and Wang, Yuanhan and Wang, Hui and Zhang, Junhong and Yang, Song},
title = {YTHDF2 negatively correlates with tumor immune infiltration in small cell lung cancer},
journal = {Journal of Molecular Histology},
year = {2023},
doi = {10.1007/s10735-023-10129-6}
}
EUVIMED